Company Filing History:
Years Active: 2004
Title: Innovations in HIV Vaccine Development by Randall Owens
Introduction
Randall Owens is an accomplished inventor based in Myersville, MD (US). He has made significant contributions to the field of medical research, particularly in the development of vaccines against human immunodeficiency viruses (HIV). His innovative work focuses on the preparation and use of viral vectors for mixed envelope protein vaccines.
Latest Patents
Owens holds a patent for the "Preparation and use of viral vectors for mixed envelope protein vaccines against human immunodeficiency viruses." This patent describes polyenv vaccines that comprise mixtures of at least 4 to about 10,000 different recombinant viruses. Each virus expresses a different HIV env variant or a portion thereof containing both constant and variable regions. The patent also outlines methods for making and using these polyenv vaccines and viruses, including their application in live, attenuated, or inactivated forms for the prophylaxis or treatment of HIV infection. The viral vaccines are optimally combined with a recombinant HIV env booster or a recombinant HIV env gene DNA priming or boosting vaccine.
Career Highlights
Randall Owens is affiliated with St. Jude Children's Research Hospital, where he continues to advance his research in vaccine development. His work is crucial in the ongoing fight against HIV, contributing to the broader efforts in public health and infectious disease management.
Collaborations
Owens collaborates with notable colleagues, including Julia Lea Hurwitz and Christopher Coleclough. Their combined expertise enhances the research and development of innovative solutions in the field of virology and immunology.
Conclusion
Randall Owens exemplifies the spirit of innovation in medical research, particularly in the development of effective vaccines against HIV. His contributions are vital in the quest for better health outcomes and the fight against infectious diseases.